Table 1. Clinical Characteristics and Tumor Location.

From: Wedge Resection for Duodenal Gastrointestinal Stromal Tumors: Surgical Management and the Clinicopathological Outcome

Case Age (year) Sex Initial symptom Findings of enhanced CT Findings of EGD Preoperative diagnosis Location Precise mural location of the duodenum
1 43 M Bleeding Enhanced mass SMT with ulceration GIST Third Anti-mesenteric
2 75 F SMT S/O GIST Anti-mesenteric
3 83 M Hematemesis SMT with ulceration Mesenteric
4 57 M Bleeding Mesenteric
5 70 M Second Anti-mesenteric
6 54 M Fourth Mesenteric
Table 2. Surgical Procedure and Histopathological and Immunohistochemical Findings.

From: Wedge Resection for Duodenal Gastrointestinal Stromal Tumors: Surgical Management and the Clinicopathological Outcome

Case Surgical operation Approach Intraoperative endoscopy Size Mitotic count TNM Stage Resectional status Tumor ulceration KIT CD34 S100 Desmin
1 Wedge resection with suturing Open None 30 mm ≧6/5 mm2 T2N0M0 IIIB R0 (+) (+) (+) (−) (−)
2 25 mm ≦5/5 mm2 T2N0M0 I R0 (−) (+) (+) (−) (−)
3 35 mm ≦5/5 mm2 T2N0M0 I R0 (+) (+) (+) (−) (−)
4 29 mm ≦5/5 mm2 T2N0M0 I R0 (+) (+) (−) (−) (−)
5 38 mm ≦5/5 mm2 T2N0M0 I R0 (+) (+) (−) (+) (−)
6 75 mm ≦5/5 mm2 T3N0M0 II R0 (+) (+) (+) (−) (−)
Table 3. Adjuvant Chemotherapy and the Outcome and Survival.

From: Wedge Resection for Duodenal Gastrointestinal Stromal Tumors: Surgical Management and the Clinicopathological Outcome

Case Postoperative complication Postoperative stay (day) Adjuvant chemotherapy Recurrence Status
1 None 11 Imatinib None 3y6m alive
2 13 None 5y alive
3 14 6y4m alive
4 10 6y3m alive
5 14 12y alive
6 15 15y8m alive
PAGE TOP